Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of April 2019
Filing Date: April 4, 2019
Principal Executive Offices: Dublin 2, Ireland
This filing serves as a cover document referencing forward-looking statements and exhibits (Appendix 3B) but does not contain the primary financial results or operational data within the text provided.
Key Financial Metrics
The provided filing text does not contain specific financial data. The following metrics are not reported in this document:
- Revenue
- Profit
- Cash Flow
- Margins
- Debt
- Liquidity
Note: The filing references "Appendix 3B" as an exhibit, which likely contains the detailed financial information, but the content of that exhibit is not included in the source text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus prior periods. It generally references the potential for results to differ from expectations due to various risk factors.
Guidance, Outlook, and Risks
Forward-Looking Statements: The document extensively lists categories of forward-looking statements, including future performance, capital expenditure projects, credit facility renewals, dividend payments, and share buy-backs.
Key Risks and Uncertainties: Management highlights several material risks that could cause actual results to differ materially from projections:
- Asbestos Liabilities: Risks related to prior asbestos product manufacture, contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls in the AICF, and currency exchange impacts on asbestos liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, consumer class action, and intellectual property proceedings.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, consumer confidence, and mortgage availability.
- Operational: Supply and cost of raw materials, competition, and integration of the Fermacell business.
- Financial: Currency exchange risks and the ability to renew credit facilities on favorable terms.
Investor Verification Checklist
- Verify the contents of Exhibit 99.1 and 99.2 (Appendix 3B), as the specific financial results and operational updates are referenced there but not included in this text.
- Review the Form 20-F filed on May 22, 2018, specifically Section 3 "Risk Factors," for a detailed discussion of the risks summarized in this filing.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF), including contribution requirements and any potential shortfalls.
- Assess the impact of currency exchange rates on the company's financial statements, particularly regarding asbestos liabilities.
- Track the status of the Fermacell integration and its impact on future performance.